Categoría: Circulares
CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19
In: Circulares, Comunicados, NoticiasThe Centers for Medicare & Medicaid Services (CMS) is supporting clinicians on the front lines by getting red tape out of the way so the healthcare delivery system can focus on the 2019 Novel Coronavirus (COVID-19) response. CMS is implementing additional extreme and uncontrollable circumstances policy exceptions and extensions for upcoming quality measure reporting and data submission deadlines for the following CMS programs:
Provider Programs | 2019 Data Submission | 2020 Data Submission |
Merit-based Incentive Payment System (MIPS) |
Deadline extended from March 31, 2020 to April 30, 2020.
MIPS eligible clinicians who have not submitted any MIPS data by April 30, 2020 will qualify for the automatic extreme and uncontrollable circumstances policy and will receive a neutral payment adjustment for the 2021 MIPS payment year. |
CMS is evaluating options for providing relief around participation and data submission for 2020. |
|
Hospital Programs | 2019 Data Submission | 2020 Data Submission |
|
Deadlines for October 1, 2019 – December 31, 2019 (Q4) data submission optional.
If Q4 is submitted, it will be used to calculate the 2019 performance and payment (where appropriate). If data for Q4 is unable to be submitted, the 2019 performance will be calculated based on data from January 1, 2019 – September 30, 2019 (Q1-Q3) and available data.
|
CMS will not count data from January 1, 2020 through June 30, 2020
(Q1-Q2) for performance or payment programs. Data does not need to be submitted to CMS for this time period.
* For the Hospital-Acquired Condition Reduction Program and the Hospital Value-Based Purchasing Program, if data from January 1, 2020 – March 31, 2020 (Q1) is submitted, it will be used for scoring in the program (where appropriate). |
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
Post-Acute Care (PAC) Programs | 2019 Data Submission | 2020 Data Submission |
|
Deadlines for October 1, 2019 – December 31, 2019 (Q4) data submission optional.
If Q4 is submitted, it will be used to calculate the 2019 performance and payment (where appropriate).
|
Data from January 1, 2020 through June 30, 2020 (Q1-Q2) does notneed to be submitted to CMS for purposes of complying with quality reporting program requirements.
* Home Health and Hospice Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey data from January 1, 2020 through September 30, 2020 (Q1-Q3) does not need to be submitted to CMS.
*For the Skilled Nursing Facility (SNF) Value-Based Purchasing Program, qualifying claims will be excluded from the claims-based SNF 30-Day All-Cause Readmission Measure (SNFRM; NQF #2510) calculation for Q1-Q2.
|
|
||
|
||
|
||
|
||
|
CMS is granting exceptions and extensions to assist health care providers and suppliers while they direct their resources toward caring for their patients and ensuring the health and safety of patients and staff. For those programs with data submission deadlines in April and May 2020, submission of those data will be optional based on the facility’s choice to report. In addition, no data reflecting services provided January 1, 2020-June 30, 2020 will be used in CMS’ calculations for the Medicare quality reporting and value-based purchasing programs in order to reduce providers’ data collection and reporting burden as they are responding to the COVID-19 pandemic.
CMS recognizes that quality measure reporting may not be reflective of performance for measures such as cost, readmissions and patient experience during this time of emergency and seeks to hold organizations harmless for data during this period. CMS will continue to monitor the situation and adjust reporting periods and submission deadlines accordingly. More detailed information about changes to each of these quality reporting programs will be provided soon.
Quality Payment Program
2019 MIPS Submission Deadline Extended: Submit 2019 Data by April 30, 2020
The 2019 Merit-based Incentive Payment System (MIPS) data submission deadline will be extended by 30 days to April 30, 2020. If you have already submitted MIPS data or if you submit MIPS data by April 30, 2020, you will be scored and receive a MIPS payment adjustment based on the data you submit. Many MIPS eligible clinicians have performed very well in the MIPS program in previous years. If you need to revise any data that has already been submitted you can still make changes by logging into qpp.cms.gov by the new deadline.
2019 MIPS Automatic Extreme and Uncontrollable Circumstances Policy Update
MIPS eligible clinicians who have not submitted any MIPS data by April 30, 2020 do not need to take any additional action to qualify for the automatic extreme and uncontrollable circumstances policy. These clinicians will be automatically identified and receive a neutral payment adjustment for the 2021 MIPS payment year. All four MIPS performance categories for these clinicians will be weighted at zero percent, resulting in a score equal to the performance threshold, and a neutral MIPS payment adjustment for the 2021 MIPS payment year. However, if a MIPS eligible clinician submits data on two or more MIPS performance categories, they will be scored and receive a 2021 MIPS payment adjustment based on their 2019 MIPS final score.
CMS will continue monitoring the developing COVID-19 situation and assess options to bring additional relief to clinicians and their staff so they can focus on caring for patients.
For More Information
Please reference the 2019 QPP Data Submission User Guide. CMS also has up to date information about its programs and response to COVID-19 on the Current Emergencies page.
For Quality Payment Program questions you can contact 1-866-288-8292, Monday through Friday, 8:00 AM-8:00 PM ET or by e-mail at:QPP@cms.hhs.gov.
- Customers who are hearing impaired can dial 711 to be connected to a TRS Communications Assistant.
CMS Coronavirus (COVID19) Partner Toolkit
In: Circulares, Comunicados, NoticiasGreetings to all providers in PR and the USVI.
In an effort to help providers stay informed about the COVID19, CMS has developed the following toolkit: https://www.cms.gov/outreach-education/partner-resources/coronavirus-covid-19-partner-toolkit. Please, navigate the link and share with the most providers as you can. Your feedback is important to us during this emergency. Let me know should you have questions related this toolkit or any related concern. My contact information is below my signature for you to reach out.
Carta Circular 20-011
In: Circulares, Normativas, NoticiasCarta Circular 20-010
In: Circulares, Normativas, NoticiasCARTA NORMATIVA 20-03-168
In: Circulares, Circulares PROSSAMCARTA NORMATIVA NUM. CN-2020-268-D
In: Circulares, Circulares PROSSAMCARTA NORMATIVA NUM. CN-2020-265-D
In: Circulares, Circulares PROSSAMCARTA NORMATIVA NÚM. CN-2020-254-D
In: Circulares, Circulares PROSSAMMLN Connects® | Edición especial – viernes 13 de marzo de 2020
In: Circulares, Comunicados, NoticiasCOVID-19: Precio de pruebas, pruebas de laboratorio de diagnóstico, precios y códigos, y cobertura de EHB
- COVID-19: Precio de pruebas, pruebas de laboratorio de diagnóstico, precios y códigos, y cobertura de EHB
- Artículo de MLN Matters® de la actualización trimestral para tarifas fijas de laboratorio clínico y servicios de laboratorio sujetos a pago de cargo razonable
- Cobertura de beneficios esenciales de salud (EHB)
COVID-19: Precio de pruebas, pruebas de laboratorio de diagnóstico, precios y códigos, y cobertura de EHB
El 12 de marzo, CMS publicó una hoja informativa (en inglés) con información relacionada al precio de los Centros para el Control y Prevención de Enfermedades (CDC) y de las pruebas que no son de los CDC.
Artículo de MLN Matters® de la actualización trimestral para tarifas fijas de laboratorio clínico y servicios de laboratorio sujetos a pago de cargo razonable
Un nuevo artículo (en inglés) de MLN Matters, MM 11681, acerca de la Artículo de MLN Matters® de la actualización trimestral para tarifas fijas de laboratorio clínico y servicios de laboratorio sujetos a pago de cargo razonable está disponible. Obtenga información sobre las pruebas de laboratorio de diagnóstico avanzado, los precios y los nuevos códigos. En la página 3, hacemos referencia a nuevos códigos COVID-19.
Cobertura de beneficios esenciales de salud (EHB)
El 12 de marzo, CMS emitió (en inglés) unas Preguntas frecuentes (FAQs) acerca de EHB para asegurar que individuos, emisores, y estados tengan información clara de beneficios de cobertura para COVID-19. Esta acción esparto del esfuerzo Esta acción es parte del esfuerzo más amplio y continuo del Coronavirus Task Force de la Casa Blanca para garantizar que todos los americanos, particularmente aquellos con alto riesgo de complicaciones por el virus COVID-19, tengan acceso a los beneficios de salud que puedan ayudarlos a mantenerse saludables mientras se ayuda a contener la propagación de esta enfermedad.
Estas preguntas frecuentes y las acciones anteriores de CMS en respuesta al virus COVID-19 son parte de los esfuerzos en curso del Task Force de la Casa Blanca. Para mantenerse al día con el importante trabajo que el Grupo de Trabajo está haciendo en respuesta a COVID-19; visite la página web (en inglés) del CDC Enfermedad del Coronavirus 2019 .
Para información específica de CMS, por favor visite la página web (en inglés) Emergencias Actuales .